Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The cancer research campaign (King's/Cambridge trial for early breast cancer: Clinico-pathological aspects

Abstract

Analysis of pathological data in the 10th year of follow-up of a multicentre trial of the management of operable breast cancer has confirmed the correlation of prognosis with tumour grade, tumour size and lymph-node status. For each factor examined there was no difference in survival between the 2 treatment groups ("watch policy" and radiotherapy) but patients in the WP group whose tumours were of Grade II or III or greater than 2 cm, or with lymph-node metastases, had a greater chance of local recurrence. Cellular reaction had no relationship with prognosis, except in patients with Grade III tumours. The clinical relevance and application of these results are discussed.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elston, C., Gresham, G., Rao, G. et al. The cancer research campaign (King's/Cambridge trial for early breast cancer: Clinico-pathological aspects. Br J Cancer 45, 655–669 (1982). https://doi.org/10.1038/bjc.1982.106

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1982.106

This article is cited by

Search

Quick links